Press release
Global Sales of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics is Expected to Reach US$ 7.3 Billion by 2027: Transparency Market Research
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics
According to Transparency Market Research's latest report on the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market for the historical periodย 2017-2018ย and forecast periodย 2019-2027,ย rise in prevalence of cystic fibrosis and chronic pancreatitis to escalate the growth of global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market. Moreover, rising cases of diabetes are expected to fuel growth of the exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ :
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2748&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR
๐๐๐ฒ ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ:
Exocrine pancreatic insufficiency (EPI) results from inadequate secretion of pancreatic enzymes such as amylase, lipase, protease, and/or sodium bicarbonate. Various conditions, including different types of diabetes, are associated with a heightened risk of EPI. A study in Current Diabetes Reports reveals a higher prevalence of EPI in type 1 diabetes compared to type 2.
The escalating incidence of diabetes, attributed to sedentary lifestyles and unhealthy diets, is a significant driver for the exocrine pancreatic insufficiency therapeutics and diagnostics market. Globally, diabetes prevalence is projected to rise from 463 million in 2019 to 578 million by 2030. This surge underscores the urgent need for new treatments.
Key players are thus investing in research and development endeavors to introduce innovative EPI therapeutics. For example, AzurRx is developing MS1819, a yeast-derived lipase engineered for superior enzymatic activity, aiming to meet the escalating demand for effective EPI treatments.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
AbbVie, Inc,Allergan plc.,Nordmark Arzneimittel GmbH & Co. KG,Digestive Care, Inc.,Janssen Pharmaceuticals, Inc.,Cilian AG, Anthera Pharmaceuticals, Inc,AzurRx Biopharma, Inc.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐ฒ๐ฉ๐
Therapeutics
Diagnostics
Blood Tests
Endoscopic Ultra-sonography (EUS)
Magnetic Resonance Imaging (MRI)
CT Scanning
๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
Inย April 2020,ย AzurRx Biopharma, Inc. has received Institutional Review Board (IRB) approval of its Phase 2 OPTION 2 clinical trial protocol to investigate MS1819 in cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI)
Inย April 2020, AzurRx Biopharma, Inc. has entered into a manufacturing agreement with Delpharm for the clinical drug product supply of its MS1819 therapy for exocrine pancreatic insufficiency (EPI)
Inย February 2020,ย Vivus Inc. announced that the U.S. Food and Drug Administration has approved the supplemental New Drug Application (sNDA) for PANCREAZE. PANCREAZE is indicated for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis or other conditions
๐๐๐ญ ๐๐ก๐ข๐ฌ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ง๐ฌ๐ญ๐๐ง๐ญ๐ฅ๐ฒ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=2748<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ก๐๐ฅ๐ฅ๐๐ง๐ ๐๐ฌ:
Key drivers of the EPI therapeutics and diagnostics market include increasing prevalence of pancreatic disorders, growing geriatric population, advancements in diagnostic techniques, and rising awareness among healthcare professionals and patients. However, challenges such as high treatment costs, limited accessibility in rural areas, and stringent regulatory approvals may hinder market growth.
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
Emerging trends in the market include the development of novel therapeutics with improved efficacy and safety profiles, increasing adoption of point-of-care testing for rapid diagnosis, and strategic collaborations among pharmaceutical companies to expand their product portfolios.
๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
The future outlook for the EPI therapeutics and diagnostics market appears promising, with continued investments in research and development, technological advancements, and expanding healthcare infrastructure expected to drive market growth.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ญ๐ฎ๐๐ฒ ๐๐จ๐ข๐ง๐ญ๐ฌ:
Key study points for market analysis include understanding the prevalence and incidence rates of EPI, evaluating the efficacy and safety profiles of existing therapeutics, assessing the market potential in emerging economies, and analyzing competitive landscape and market dynamics.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐๐:
๐๐ฅ๐๐๐ญ๐ซ๐ข๐ ๐๐๐ก๐ข๐๐ฅ๐ ๐๐๐ญ๐ญ๐๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญ-https://www.globenewswire.com/news-release/2023/05/08/2663718/0/en/Electric-Vehicle-Battery-Market-Demand-will-reach-a-value-of-US-365-4-Billion-by-the-year-2031-at-a-CAGR-of-21-9-Exclusive-Report-by-Transparency-Market-Research.html
๐๐ข๐ง๐๐ซ๐๐ฅ ๐๐ฎ๐ง๐ฌ๐๐ซ๐๐๐ง ๐๐๐ซ๐ค๐๐ญ-https://www.globenewswire.com/news-release/2023/05/08/2663684/0/en/Mineral-Sunscreen-Market-Revenue-to-Reach-USD-1-6-Bn-by-2031-growing-at-a-CAGR-of-5-4-Reveals-TMR-Study.html
ย
๐๐๐จ๐ฎ๐ญ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
Transparency Market Research, a globalย market research companyย registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website:ย https://www.transparencymarketresearch.comย ย ย ย ย
Email:ย ย sales@transparencymarketresearch.com
Follow Us:ย LinkedIn|ย Twitter|ย Blogย |ย YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Sales of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics is Expected to Reach US$ 7.3 Billion by 2027: Transparency Market Research here
News-ID: 3409159 • Views: โฆ
More Releases from Transparency Market Research
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost โฆ
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035.
Gain a preview of important insights fromโฆ
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A โฆ
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035.
Access key findingsโฆ
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig โฆ
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)โฆ
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b โฆ
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035.
Access keyโฆ
More Releases for EPI
Emerging Trends to Reshape the Silicon EPI Wafer Market: Next-Generation Silicon โฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Silicon EPI Wafer Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of the silicon epi wafer has experienced consistent expansion in the previous years, seeing a projected rise from a value of $1.8 billion in 2024 to $1.89 billion in 2025. Thisโฆ
Consumer Electronics Adoption Fuels The Silicon Epi Wafer Market: Core Growth En โฆ
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Silicon EPI Wafer Industry Market Size Be by 2025?
Over recent years, the market size for silicon EPI wafers has seen considerable growth. Predictions indicate an increase from $1.8 billion in 2024 to $1.92 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historicalโฆ
Evolving Market Trends In The Silicon EPI Wafer Industry: Next-Generation Silico โฆ
The Silicon EPI Wafer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Silicon EPI Wafer Market Size During the Forecast Period?
In recent times, the silicon EPI wafer market has witnessed substantial growth. The market size, which stood at $1.8 billion inโฆ
EPI Invests $1 Million USD in the EPI Data Center Futurist Scholarship Program
Singapore (15 June 2023) - EPI, the global leader in data center training, audit & certification, is proud to announce the launch of the EPI Data Center Futurist Scholarship program, accompanied by a significant investment of one (1) million US-Dollar. This transformative initiative aims to provide aspiring professionals with the resources and support they need to acquire the specialized knowledge and skills necessary for success in the dynamic dataโฆ
Epi Wafer Market to Surpass Valuation of US$ 5.8 Bn by 2030 with Rising Demand f โฆ
The global Epi Wafer market is estimated to attain a valuation of US$ 5.8 billion by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders ofโฆ
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohnโs disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPIโฆ
